Identification of biomarkers, new treatments, and vaccines for COVID-19 / Paul C. Guest, editor.
Guest, Paul C., editor.
2021
R853.B54
Available Online

Linked e-resources

Linked Resource
Online Access
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks

Details

Title
Identification of biomarkers, new treatments, and vaccines for COVID-19 / Paul C. Guest, editor.
ISBN
9783030716974 (electronic bk.)
303071697X (electronic bk.)
3030716961
9783030716967
DOI
https://doi.org/10.1007/978-3-030-71697-4
Publication Details
Cham : Springer, 2021.
Language
English
Description
1 online resource (229 pages)
Item Number
10.1007/978-3-030-71697-4 doi
Call Number
R853.B54
Dewey Decimal Classification
610.28
Summary
The novel coronavirus 2019 (COVID-19) has caused a serious global pandemic in just one year. Nearly every country and territory in the world has been affected by the virus. The virulence and infection rate of the virus are profound, and has required extreme social distancing measures across the globe in order to prevent overwhelming the healthcare services and hospitals. COVID-19 appears to have the greatest effects on elderly individuals and those who have co-morbid diseases, such as diabetes and obesity. As the cases and death rate remain high, there are justified fears of this virus remaining for several months or years to come. To address this, a rapid and unprecedented worldwide mobilization effort has begun to identify effective treatments and develop vaccines. As these begin to be deployed and administered across the globe, many now feel the virus will be brought under control and lives will eventually return to normal. This new volume will increase readers understanding of the ongoing COVID-19 pandemic through a series of chapters that address these concerns. Leading experts will discuss new treatment approaches, vaccine development, mental health aspects of the pandemic, and convey the results of survey studies. The book will be an excellent resource for researchers studying virology, metabolic diseases, respiratory disorders, and clinical scientists, physicians, drug companies, and healthcare services and workers.
Note
11 Adaptive Immune Response and Age-Related Difference.
Includes index.
Bibliography, etc. Note
References-3: COVID-19 Pandemic in Brazil: History, Characteristics, and Evolution-1 Brief Historical Facts of the COVID-19 Pandemic in Brazil-2 Governmental Measures to Combat the Pandemic-3 Regional Characteristics Influencing the COVID-19 Dissemination-4 Prevalence of the Disease in Different Subpopulations-5 Concluding Remarks-References-4: The Experiences of Recovered COVID-19 Patients in Baqiyatallah Hospital: A Qualitative Study-1 Introduction-2 Methods-2.1 Data Collection-2.2 Data Analysis-3 Results.
Access Note
Access limited to authorized users.
Digital File Characteristics
text file
PDF
Source of Description
Online resource; title from PDF title page (SpringerLink, viewed August 5, 2021).
Added Author
Guest, Paul C., editor.
Series
Advances in experimental medicine and biology ; v. 1327.
Advances in experimental medicine and biology. Proteomics, metabolomics, interactomics and systems biology.
Available in Other Form
Identification of Biomarkers, New Treatments, and Vaccines for COVID-19.
Linked Resources
Online Access
Record Appears in
Online Resources > Ebooks
All Resources
5: Age-Specific Differences in the Severity of COVID-19 Between Children and Adults: Reality and Reasons
1 Introduction
2 Age-Related Effects of Different Infections
3 Age Effects of COVID-19 Disease
4 Clinical Features in Children
5 The Different Etiology and Severity of COVID-19 Based on Age
6 Underlying Conditions and Severity of COVID-19 in Children
7 Outdoor Activities and the Potential to Contract the Virus
8 Immune System and Age-Related Differences
9 Innate Immune Cells and Age-Related Differences
10 IFN and SARS-CoV in Children

Intro
Preface
Contents
Part I: Background
1: Genetic Aspects and Immune Responses in Covid-19: Important Organ Involvement
1 Introduction
2 Epidemiology
3 Main Coronavirus Groups
4 Genome, Genotype, and Protein Structure
5 Mechanism of Infection
6 COVID-19 Pathogenesis
7 Respiratory Manifestations
8 Extra-pulmonary Presentations
8.1 Gastrointestinal Manifestations
8.2 Cardiovascular Complications
8.3 Haematological Disorders
9 Immune Responses
10 Therapy
10.1 Drugs that Slow Viral Replication or Kill SARS-Cov-2

10.2 Vaccination
11 Conclusion
References
Part II: Epidemiology
2: Prevalence of COVID-19 and the Continued Citizen-Based Control in Japan
1 Introduction
2 Cruise Ship Outbreak and the Environmental Assessment
2.1 COVID-19 Outbreak on the Diamond Princess Cruise Ship
2.2 Age-Related CFR Estimated from the Cruise Ship Outbreak
2.3 Environmental Assessment of SARS-CoV-2 on the Cruise Ship
3 Government-Recommended and Voluntary Measures to Protect Against COVID-19 Infection in Japan
4 Detection of the Coronavirus in Laboratories in Japan
5 Conclusions

3.1 Theme I: Emotional-Sensational-Paradox
Satisfaction-Dissatisfaction
Positive Experiences-Negative Experiences
Relaxation-Stress
Support-Rejection
3.2 Theme II: Spiritual Growth
Accepting and Submitting to Divine Providence
Rethinking Material Possessions
Seeking Stronger Divine Connection
Tendency to Spirituality
3.3 Theme III: Experienced Mental-Psychological Effects
Unpleasant Thoughts
Perceived Mental Stress
Positive Thoughts
4 Discussion
5 Conclusions
References
Part III: Risk Factors and Outcomes

Browse Subjects

Show more subjects...

Statistics

from
to
Export